3.01
price up icon2.73%   0.08
after-market アフターアワーズ: 3.02 0.01 +0.33%
loading
前日終値:
$2.93
開ける:
$2.93
24時間の取引高:
465.41K
Relative Volume:
0.47
時価総額:
$500.64M
収益:
-
当期純損益:
$-54.70M
株価収益率:
-9.1212
EPS:
-0.33
ネットキャッシュフロー:
$-51.36M
1週間 パフォーマンス:
+14.02%
1か月 パフォーマンス:
+7.12%
6か月 パフォーマンス:
-17.53%
1年 パフォーマンス:
-39.31%
1日の値動き範囲:
Value
$2.89
$3.02
1週間の範囲:
Value
$2.60
$3.047
52週間の値動き範囲:
Value
$2.31
$5.31

Savara Inc Stock (SVRA) Company Profile

Name
名前
Savara Inc
Name
セクター
Healthcare (1151)
Name
電話
51285113796
Name
住所
6836 BEE CAVE ROAD, AUSTIN, TX
Name
職員
59
Name
Twitter
@SavaraPharma
Name
次回の収益日
2025-03-26
Name
最新のSEC提出書
Name
SVRA's Discussions on Twitter

SVRA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
SVRA
Savara Inc
3.01 500.64M 0 -54.70M -51.36M -0.33
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
489.10 127.47B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.16 62.43B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
596.20 37.03B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
234.56 31.06B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
230.98 26.16B 3.81B -644.79M -669.77M -6.24

Savara Inc Stock (SVRA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-12-20 開始されました Wells Fargo Overweight
2024-11-13 ダウングレード Evercore ISI Outperform → In-line
2024-02-15 開始されました JMP Securities Mkt Outperform
2023-11-07 開始されました Guggenheim Buy
2023-05-16 アップグレード Jefferies Hold → Buy
2023-03-31 ダウングレード Jefferies Buy → Hold
2021-03-16 開始されました Piper Sandler Overweight
2021-03-15 開始されました Oppenheimer Outperform
2019-06-13 繰り返されました H.C. Wainwright Buy
2019-06-13 ダウングレード JMP Securities Mkt Outperform → Mkt Perform
2019-06-13 ダウングレード Ladenburg Thalmann Buy → Neutral
2018-08-13 再開されました ROTH Capital Neutral
2018-01-03 開始されました Ladenburg Thalmann Buy
2017-09-27 再開されました ROTH Capital Buy
2017-09-22 開始されました Jefferies Buy
2017-09-11 開始されました JMP Securities Mkt Outperform
すべてを表示

Savara Inc (SVRA) 最新ニュース

pulisher
Apr 18, 2025

Savara Inc. Announces Equity Awards for New Employees - MSN

Apr 18, 2025
pulisher
Apr 15, 2025

Savara Inc (NASDAQ:SVRA) Shares Purchased by Vanguard Group Inc. - Defense World

Apr 15, 2025
pulisher
Apr 14, 2025

Corebridge Financial Inc. Sells 4,330 Shares of Savara Inc (NASDAQ:SVRA) - Defense World

Apr 14, 2025
pulisher
Apr 13, 2025

KLP Kapitalforvaltning AS Purchases Shares of 13,200 Savara Inc (NASDAQ:SVRA) - Defense World

Apr 13, 2025
pulisher
Apr 12, 2025

Savara Announces New Employment Inducement Grant | SVRA Stock Ne - GuruFocus

Apr 12, 2025
pulisher
Apr 11, 2025

Savara Announces New Employment Inducement Grant - Bluefield Daily Telegraph

Apr 11, 2025
pulisher
Apr 11, 2025

Savara Inc (NASDAQ:SVRA) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World

Apr 11, 2025
pulisher
Apr 10, 2025

Savara Inc. Launches Convenient DBS Test for Diagnosing Rare Lung Disease - MSN

Apr 10, 2025
pulisher
Apr 07, 2025

Savara to present aPAP treatment study at medical congresses By Investing.com - Investing.com Canada

Apr 07, 2025
pulisher
Apr 07, 2025

Savara to present aPAP treatment study at medical congresses - Investing.com

Apr 07, 2025
pulisher
Apr 07, 2025

Savara Announces Encore Presentations From the Phase 3 IMPALA-2 Trial of Molgramostim Inhalation Solution (Molgramostim) in Patients With Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at Two Upcoming Scientific Conferences - MarketScreener

Apr 07, 2025
pulisher
Apr 07, 2025

Breakthrough Phase 3 Results: New Treatment Could Transform Rare Lung Disease Management - Stock Titan

Apr 07, 2025
pulisher
Apr 06, 2025

259,798 Shares in Savara Inc (NASDAQ:SVRA) Bought by Raymond James Financial Inc. - Defense World

Apr 06, 2025
pulisher
Apr 04, 2025

Savara Completes BLA Submission for MOLBREEVI to Treat aPAP - MSN

Apr 04, 2025
pulisher
Apr 03, 2025

Health Check: How Prudently Does Savara (NASDAQ:SVRA) Use Debt? - simplywall.st

Apr 03, 2025
pulisher
Apr 02, 2025

Savara Reports 2024 Financial Results and Provides Updates on MOLBREEVI Progress - MSN

Apr 02, 2025
pulisher
Apr 02, 2025

Savara Secures $200 Million Loan Agreement with Hercules Capital - MSN

Apr 02, 2025
pulisher
Apr 02, 2025

Savara IncTerminates ATM Agreement With Evercore Effective April 2, 2025SEC Filing - marketscreener.com

Apr 02, 2025
pulisher
Apr 01, 2025

Savara director David Ramsay acquires $416,250 in common stock By Investing.com - Investing.com Australia

Apr 01, 2025
pulisher
Apr 01, 2025

Savara Insider Bought Shares Worth $416,250, According to a Recent SEC Filing - MarketScreener

Apr 01, 2025
pulisher
Apr 01, 2025

Savara director David Ramsay acquires $416,250 in common stock - Investing.com India

Apr 01, 2025
pulisher
Apr 01, 2025

Q1 Earnings Forecast for Savara Issued By HC Wainwright - The AM Reporter

Apr 01, 2025
pulisher
Mar 31, 2025

Savara’s SWOT analysis: rare disease biotech stock eyes FDA approval By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

SAVARA Earnings Preview: Recent $SVRA Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 31, 2025
pulisher
Mar 31, 2025

Savara Inc ends sales agreement with Evercore By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

Savara Inc ends sales agreement with Evercore - Investing.com

Mar 31, 2025
pulisher
Mar 31, 2025

Savara’s SWOT analysis: rare disease biotech stock eyes FDA approval - Investing.com India

Mar 31, 2025
pulisher
Mar 31, 2025

Swiss National Bank Decreases Stock Holdings in Savara Inc (NASDAQ:SVRA) - Defense World

Mar 31, 2025
pulisher
Mar 31, 2025

What is HC Wainwright’s Estimate for Savara Q1 Earnings? - Defense World

Mar 31, 2025
pulisher
Mar 30, 2025

HC Wainwright Reaffirms Buy Rating for Savara (NASDAQ:SVRA) - Defense World

Mar 30, 2025
pulisher
Mar 28, 2025

Savara enters loan and security agreement with Hercules Capital - MSN

Mar 28, 2025
pulisher
Mar 28, 2025

Savara stock holds Buy rating, $6 target from H.C. Wainwright By Investing.com - Investing.com Australia

Mar 28, 2025
pulisher
Mar 28, 2025

Savara stock holds Buy rating, $6 target from H.C. Wainwright - Investing.com India

Mar 28, 2025
pulisher
Mar 28, 2025

Charles Schwab Investment Management Inc. Grows Position in Savara Inc (NASDAQ:SVRA) - Defense World

Mar 28, 2025
pulisher
Mar 27, 2025

Nkarta to lay off 34% of staff; Savara’s debt financing deal - Endpoints News

Mar 27, 2025
pulisher
Mar 27, 2025

Savara Inc. (SVRA) reports earnings - Quartz

Mar 27, 2025
pulisher
Mar 27, 2025

Savara Reports Fourth Quarter and Year End 2024 Financial Results and Provides Business Update - Joplin Globe

Mar 27, 2025
pulisher
Mar 27, 2025

Breakthrough: Savara Advances First-Ever aPAP Treatment with FDA Filing, Reports $196M Cash Position - Stock Titan

Mar 27, 2025
pulisher
Mar 27, 2025

JMP maintains $9 target on Savara stock, sees FDA nod By Investing.com - Investing.com South Africa

Mar 27, 2025
pulisher
Mar 27, 2025

JMP maintains $9 target on Savara stock, sees FDA nod - Investing.com India

Mar 27, 2025
pulisher
Mar 26, 2025

Savara secures $200M loan to support respiratory drug launch By Investing.com - Investing.com South Africa

Mar 26, 2025

Savara Inc (SVRA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$20.04
price up icon 2.51%
$72.65
price up icon 3.49%
$32.60
price up icon 1.27%
$24.61
price up icon 6.77%
$98.76
price up icon 0.52%
biotechnology ONC
$230.98
price up icon 1.24%
大文字化:     |  ボリューム (24 時間):